BUY Neuland Laboratories Limited — Nirav Vora, JM Financial
byNirav Vora, JM FinancialHorizon: 1 year14 May 2026via ET Now
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·22 Sept · today
Neuland Laboratories has accelerated its peptide manufacturing expansion with the operational launch of its first commercial peptide manufacturing module. The company plans further capacity expansion
NSE · Press Release·15 Sept · 1w ago
Neuland Laboratories has accelerated its peptide manufacturing expansion with the operational launch of its first commercial peptide manufacturing module. The company plans further expansion to meet r
BSE · Company Update·15 Sept · 1w ago
6 superstar investors, 6 big bets of Madhusudan Kela, Ashish Kacholia & others
NewsEt-Markets·9 Sept · 2w ago
Neuland Labs clears ₹126 crore capex for 134 acres of land in Andhra Pradesh’s Kakinada
NewsCnbc-Tv18·7 Sept · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.